Survival in human colorectal cancer correlates with expression of the T-cell costimulatory molecule OX-40 (CD134)

This publication has 31 references indexed in Scilit:

• OX-40: life beyond the effector T cell stage
  Seminars in Immunology, 1998
• Histocompatibility Leukocyte Antigen-A2402-restricted Cytotoxic T Lymphocytes Recognizing Adenocarcinoma in Tumor-infiltrating Lymphocytes of Patients with Colon Cancer
  Japanese Journal of Cancer Research, 1997
• The cytokine microenvironment of human colon carcinoma: Lymphocyte expression of tumor necrosis factor-α and interleukin-4 predicts improved survival
  Cancer, 1996
• Assessment of invasive growth pattern and lymphocytic infiltration in colorectal cancer
  Histopathology, 1996
• The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells.
  The Journal of Experimental Medicine, 1996
• Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma
  The Lancet, 1994
• Human colorectal tumour infiltrating lymphocytes express activation markers and the CD45RO molecule, showing a primed population of lymphocytes in the tumour area.
  Gut, 1994
• Characterization of activated lymphocytes in colon cancer
  Clinical Immunology and Immunopathology, 1989
• Expression of MHC class I and class II antigens in colonic carcinomas
  Pathology, 1989
• Antigens of activated rat T lymphocytes including a molecule of 50,000 Mr detected only on CD4 positive T blasts
  Molecular Immunology, 1987